Dark Mode
Global Synthetic Cannabinoid and NPS Prevalence Data
Synthetic Data Generation
Tags and Keywords
Trusted By
"No reviews yet"
Free
About
The data provides an essential resource for analysing the global landscape of drug prevalence, drawn from research compiled for the World Drug Report 2022. It focuses particularly on the use of New Psychoactive Substances (NPS), such as synthetic cannabinoids, detailing usage rates across various countries and demographic groups. The findings aim to assist Member States in anticipating threats from drug markets and mitigating their consequences, supporting broader efforts related to health and security.
Columns
- NPS Type: The general classification of the New Psychoactive Substance being examined (e.g., Synthetic cannabinoids).
- Region, Sub-region, Country/Territory: Detailed geographical identifiers for the location where the data was collected.
- Substance: The specific drug entity under review.
- Lifetime, Past year, Past Month: Statistical percentage measures of population use over different time frames. These metrics include breakdowns for Total population, Male, and Female users.
- Year: The year the prevalence data was recorded or published.
- Age: The specific age range covered by the population sample (e.g., 15-64 or 19-30).
- Source: The originating survey or monitoring body that provided the statistics.
- Prevalence: Detailed percentage figures showing specific prevalence rates.
- Drugs: Broader categorisations of drug types, including Cannabis, Opioids (opiates and prescription opioids), and Amphetamine-type stimulants.
- Lower/Upper: Statistical values representing the lower and upper bounds of confidence intervals for prevalence estimates.
- Number/Percent/Other: Auxiliary statistical measures related to the reported data points.
Distribution
The data is typically provided in a CSV file format, suitable for analytical processing. It relates to survey microdata gathered for global drug assessment. The structured file contains 18 distinct columns detailing usage statistics and geographical/temporal context. While the precise total record count may vary depending on the specific release, the underlying structure supports statistical observations across multiple reporting countries and years.
Usage
This dataset is ideal for statistical and scientific research into global substance prevalence. It can be used for forecasting drug market trends, developing targeted public health policies, and examining the connection between substance markets and global governance issues. It offers valuable baseline data for researchers addressing the Sustainable Development Goals related to health and well-being.
Coverage
The data offers global coverage, with detailed prevalence statistics spanning multiple regions. Geographical areas represented include North Africa (Egypt), North America (Mexico, United States of America), and Central America (Costa Rica). The time frame is extensive, with records ranging from approximately 2011 up to 2020. Demographically, the scope primarily covers the population aged 15-64, often broken down into specific age cohorts (e.g., 19-30) and segregated by sex (Total, Male, Female).
License
CC0: Public Domain
Who Can Use It
Researchers affiliated with universities, international organisations, public administrations, statistical offices, and NGOs are the intended primary users. The data is suitable for statisticians, policy makers, and academics focused on health, security, and governance implications related to substance abuse. Access to the survey microdata is typically granted for statistical and scientific research purposes only, requiring researchers to adhere to specific terms and conditions.
Dataset Name Suggestions
- Global Synthetic Cannabinoid and NPS Prevalence Data
- World Drug Report Annual Prevalence Statistics
- Drug Use Statistics by Age and Geography
Attributes
Original Data Source: Global Synthetic Cannabinoid and NPS Prevalence Data
QUALITYLoading...